April 29th 2025
Brett Casper explores the marketplace complexities that manufacturers face regularly.
April 16th 2025
The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through to commercialization.
March 12th 2025
The partnership focuses on enhancing the patient experience by providing greater affordability and access to specialty meds.
February 24th 2025
The injection for the treatment of psoriatic arthritis—among other indications—is a biosimilar to Stelara.
January 14th 2025
The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Digital pills, aka ‘ingestible sensors’, are at a crossroads
Proteus Digital Health, a pioneer, crashes and burns, while EtectRx appoints a new CEO
IQVIA productizes its Ada machine intelligence in orchestrated salesforce management
More complex sales cycles, combined with more digitization of the sales process, calls for better engagement tools
Strategies for effective patient services programs
Addressing continued hurdles in patient adherence
Walgreens takes another stab at retail clinics with VillageMD partnership
Company will invest $1 billion to open 500-700 clinics at its pharmacies over five years
Book review: The Price of Global Health, 3rd edition
Ed Schoonveld’s compilation on pricing strategies gets updated for the 2020s
More Than Ever, New Therapies Require Reimbursement Support
Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges
Kalderos’ 340b management tools will broaden with new funding
Company pitches a mfr-payer-provider-patient collaboration for drug pricing
Get a flash reading of physician sentiment with COVIDPulse
Trinity Life Sciences offers a way to measure changing physician practices during the pandemic
UBC offers ‘intelligent mobile messaging’ in patient support programs
Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction
CMS should reimburse community pharmacists for at-home drug delivery, says NCPA
Position highlights the move toward more at-home services
Planning for the surge: Taking a proactive approach to benefits re-verification season
Use of an eBV system can save months of re-verification work and >$100,000 in operational costs
The impact of Covid-19 across market access stakeholders and what it means for manufacturers
Pharma marketing will have to adjust to a new reality
Copay maximizers have murky financial implications, says Drug Channels
The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions
How to successfully transition patient solutions providers
Reasons for, and actions to take, when switching hub service providers
Integrichain adds more managed services to its commercialization IT business
Acquisition of Cumberland Life Sciences boosts its client base and range of services
Patient support in the pandemic era
Hub service providers look to telehealth to expand patient connectivity
Navigating the patient journey after rare disease diagnosis
Commercial teams can prepare for overcoming predictable hurdles
Evolving Patient Access Programs for Specialty Therapies
When a physician prescribes or treats a patient with your specialty drug, the stakes are high for everyone. Patient access is evolving to improve the patient and physician journey with specialty therapies
Tips on running virtual meetings
For sessions with co-workers or clients, consider these recommendations
Sales growth of pharmaceuticals is slowing globally, says IQVIA annual study
US list-price sales reached $510 billion in 2019
Specialty pharmaceutical patients ‘have difficulty’ obtaining their first dose
CoverMyMeds report gives evidence of ongoing difficulties in patient support
Pondering the shrinking number of retail pharmacies
PCMA study disputes its members’ harm to brick-and-mortar businesses
2020 Patient Support / Hub Services Report
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
‘Drugs to Watch’ list tags 11 about-to-be-approved therapies with blockbuster potential
Clarivate Analytics predicts both approvals and commercial potential
Eversana takes on a full-scale pharma commercialization
Deal with Evoke Pharmaceuticals anticipates FDA approval
Another go at consumer-level blood testing for chronic disease
Finland’s Nightingale Health opens a blood-draw center for consumers in Helsinki
Gathering to take stock of hub services
CBI meeting will highlight new advances in market access via hub services
Conduent proposes an augmented-reality linkage to prescription containers
Transforming the container to an interactive portal
PhRMA, Pacific Research studies document lower revenue growth for US pharma
Medvantx doubles capacity at its ‘end of runway’ pharmacy
Location near UPS’ WorldPort hub in Louisville, KY, enables fast prescription turnarounds